Skip to main content
. 2000 Aug;50(2):146–153. doi: 10.1046/j.1365-2125.2000.00234.x

Figure 1.

Figure 1

Epo vs Hb levels (medians and interquartile ranges) of healthy volunteers (♦) and patients in every chemotherapeutic course, distinguished in precourse (▪) and mid-course (□) of platinum treatment; precourse (•) and mid-course (○) of non platinum treatment.